Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7858703 | 1.00 | TSHR (0.30) | TSHRNLRP3 | |
| SCHEMBL7262903 | 1.00 | TSHR (0.30) | TSHRNLRP3 | |
| Hydrochloric Acid SCHEMBL25380883 | 0.98 | — | — | |
| SCHEMBL5067027 | 0.92 | — | — | |
| SCHEMBL5063697 | 0.92 | — | — | |
| Glycerin SCHEMBL7951846 | 0.90 | — | — | |
| SCHEMBL5065012 | 0.90 | — | — | |
| SCHEMBL26653603 | 0.90 | — | — | |
| SCHEMBL23384350 | 0.90 | TSHR (0.31) | TSHR | |
| SCHEMBL9235878 | 0.89 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1800 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103480-A1 | NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME | SANOFI SA (FR) | 2026-04-16 | — | — | US | claimed |
| US-20250092082-A1 | PHOTON GENERATING SUBSTRATES FOR OLIGONUCLEOTIDE SYNTHESIS | MICROSOFT TECHNOLOGY LICENSING, LLC | 2025-03-20 | — | — | US | claimed |
| CN-112105625-B | Nucleotide precursors, nucleotide analogs and oligomeric compounds containing the same | 赛诺菲 | 2024-12-31 | — | — | CN | claimed |
| CN-119173522-A | Methods and compounds | ATD生物有限公司 | 2024-12-20 | — | — | CN | claimed |
| US-20240376137-A1 | NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME | SANOFI SA (FR) | 2024-11-14 | — | — | US | claimed |
| CN-118178675-A | Supermolecule DNA-PEG-Ferrocene nano gel, preparation method and anti-tumor application | 武汉科技大学 | 2024-06-14 | — | — | CN | claimed |
| EP-4367244-A1 | OLIGONUCLEOTIDE-BASED DELIVERY VEHICLE FOR OLIGONUCLEOTIDES AGENTS AND METHODS OF USE THEREOF | Ractigen Therapeutics (CN) | 2024-05-15 | — | — | EP | claimed |
| CN-117916374-A | Oligonucleotide-based delivery vehicles for oligonucleotide agents and methods of use thereof | 中美瑞康核酸技术(南通)研究院有限公司 | 2024-04-19 | — | — | CN | claimed |
| EP-4341270-A1 | CHEMICAL PHOSPHORYLATION REAGENTS, PREPARATION, AND THEIR USES | Olix US, Inc. (US) | 2024-03-27 | — | — | EP | claimed |
| CN-117580848-A | Chemical phosphorylating reagent, preparation and use thereof | 奥利克斯美国公司 | 2024-02-20 | — | — | CN | claimed |
| WO-2001052902-A1 | ANTISENSE MODULATION OF INDUCIBLE NITRIC OXIDE SYNTHASE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2001-07-26 | — | — | WO | claimed |
| EP-1019534-A1 | MULTIFUNCTIONAL LINKING REAGENTS FOR SYNTHESIS OF BRANCHED OLIGOMERS | BIOGENEX LABORATORIES (US) | 2000-07-19 | — | — | EP | claimed |
| WO-2000040590-A2 | FUNCTIONALISED POLYNUCLEOTIDE COMPOUND, OPTIONALLY MARKED AND METHOD FOR DETECTING A TARGET NUCLEIC ACID | BIO MERIEUX (FR) | 2000-07-13 | — | — | WO | claimed |
| US-5916750-A | NON-NUCLEOSIDIC PHOSPHORAMIDITES BASED ON 1,3,5-TRIS(2-HYDROXYETHYL)CYANURIC ACID USED TO CONSTRUCT MULTIPLY-LABELED, BRANCHED DNA OLIGOMER PROBES | BIOGENEX LABORATORIES (US) | 1999-06-29 | — | — | US | claimed |
| WO-1998030719-A1 | MULTIFUNCTIONAL LINKING REAGENTS FOR SYNTHESIS OF BRANCHED OLIGOMERS | BIOGENEX LABORATORIES (US) | 1998-07-16 | — | — | WO | claimed |
| EP-0759927-B1 | PTERIDINE NUCLEOTIDE ANALOGS AS FLUORESCENT DNA PROBES | US GOV HEALTH & HUMAN SERV (US) | 1998-06-24 | — | — | EP | claimed |
| US-5677439-A | PREVENTION GENE EXPRESSION | SANOFI (FR) | 1997-10-14 | — | — | US | claimed |
| US-5648480-A | Process for making oligonucleotides having modified internucleoside linkages | NORTHWESTERN UNIVERSITY (US) | 1997-07-15 | — | — | US | claimed |
| US-5218102-A | Easily synthesized, hybridize well with target sequences | IMPROBIO (BE) | 1993-06-08 | — | — | US | claimed |
| EP-0334694-A1 | Nucleic acid probes with non-radioactive labels, and preparation processes | LA REGION WALLONNE (BE) | 1989-09-27 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103480-A1 | NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME | NSUN2, NSUN3, SNRPA | TSHR 1010/4885NLRP3 4097/4885 |
| US-20240376137-A1 | NUCLEOTIDE PRECURSORS, NUCLEOTIDE ANALOGS AND OLIGOMERIC COMPOUNDS CONTAINING THE SAME | RNMT, NSUN2, ADAR | TSHR 3889/4885NLRP3 2968/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.